Free Trial

Falling Fast, Rising Soon? 3 Stocks With Upside Ahead

Business, Technology, Internet and network concept. Financial Graph. Stock Market chart. Forex Investment. - stock image

Key Points

  • Allot, Ardent Health, and Group 1 Automotive have all faced share price declines in recent weeks or months.
  • Still, analysts are bullish on all three companies for various reasons, expecting them to be able to reverse course.
  • Investors should be cognizant of industry- or company-specific risks, but these firms may present a buy-the-dip opportunity.
  • MarketBeat previews top five stocks to own in October.

Volatility can present an opportunity to buy compelling securities at a comparably low price, provided that an investor is willing to take on a certain degree of risk. Of course, it's not a guarantee that a company with a falling share price will reverse course and yield returns, but investors set themselves up with better chances of success when they identify strong candidates.

Three firms experiencing recent dips may give investors a chance to buy at a bargain, if bullish analysts are to be believed. The companies below represent different industries and sectors and have seen varied performance in recent months, but analysts expect each of them to stage a turnaround. Those with the tolerance to ride out potential continued volatility until that time may be able to win eventual gains.

Strategic Shift and an Earnings Beat for Allot

Allot Today

Allot Ltd. stock logo
ALLTALLT 90-day performance
Allot
$9.88 -0.39 (-3.80%)
As of 09/24/2025 04:00 PM Eastern
52-Week Range
$2.78
$10.77

Telecommunications intelligence and security services provider Allot Ltd. NASDAQ: ALLT has performed well so far in 2025, rising by more than 26% since the start of the year. However, ALLT shares have had a difficult summer, falling by about 16% in the last month. The company's products have widespread applications—they are designed to provide security management infrastructure allowing providers to monitor, report, and analyze a wide variety of attacks.

The company's lackluster month has come amid its latest earnings report from June 24. Allot beat analyst predictions with earnings per share (EPS) of 2 cents compared to a predicted loss, and with revenue of $24.9 million above an expected $24.4 million. However, investors may have been spooked by the company's apparent shift away from its core products business, as revenues in this area declined year-over-year (YOY), in favor of services. While the shift may generate near-term instability, it may ultimately allow Allot to be more nimble with its spending and to better meet customer demand in a shifting environment.

The shift may already be paying off, as Allot announced in July a multi-year agreement valued at tens of millions of dollars with a Tier-1 telecom operator in EMEA.

External Challenges May Not Hinder Fast-Growing Ardent

Ardent Health Today

Ardent Health, Inc. stock logo
ARDTARDT 90-day performance
Ardent Health
$13.44 +0.22 (+1.66%)
As of 09/24/2025 03:59 PM Eastern
52-Week Range
$10.10
$20.72
P/E Ratio
7.43
Price Target
$19.33

Diversified healthcare company Ardent Health Services NYSE: ARDT went public just over a year ago and recently reached its lowest share price since that time. A decline of more than 15% in the last month has compounded issues from earlier in the year as well, amid significant challenges for the healthcare sector as a whole.

Ardent, which focuses on community hospitals across the United States, could suffer from the One Big Beautiful Bill and its cuts to Medicaid. However, investors may want to keep in mind that the potential risks of this legislation—as significant as they are—may already be priced into shares of ARDT. What's more, Ardent recently posted a sizable earnings beat with EPS of 29 cents per share, 8 cents above predictions. Revenue growth has also been consistent.

Ardent's management has taken a thoughtful but proactive approach amid the external challenges facing the company, prioritizing higher-margin operations and working to fuel EBITDA and continued revenue gains. Analysts are also optimistic: Wall Street anticipates that Ardent's earnings could climb by nearly 60% in the next year.

Despite the risks, Ardent is attractively priced, with a price-to-earnings (P/E) ratio of just 6.8 compared with a sector-wide average of 28.1. Eleven out of 13 analysts rate ARDT a Buy, expecting upside potential of more than 85%.

Resilient Top- and Bottom-Line Performance for Group 1 Despite External Headwinds

Group 1 Automotive Today

Group 1 Automotive, Inc. stock logo
GPIGPI 90-day performance
Group 1 Automotive
$448.16 -5.77 (-1.27%)
As of 09/24/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
52-Week Range
$344.38
$490.09
Dividend Yield
0.45%
P/E Ratio
12.36
Price Target
$476.57

Group 1 Automotive Inc. NYSE: GPI is a retailer selling and servicing both new and used vehicles. Despite turbulence throughout 2025, the company's shares are trading down only 1% year-to-date (YTD). However, they've dropped by about 8% in the last month amid renewed concerns about inflation and dampening consumer spending.

Group 1's recent performance suggests these worries may be unfounded for this company. The firm solidly topped analyst predictions for first-quarter EPS, coming in 49 cents ahead of forecasts for EPS of $10.17. Quarterly revenue growth was especially strong at over 23% YOY, also beating estimates.

Looking ahead, Group 1 is set to report its Q2 2025 earnings on July 24 before the market opens, a potential catalyst for a rebound if momentum continues. This may be part of the reason a number of analysts have issued optimistic predictions for the next quarter and why Wall Street sees roughly 14% upside in GPI shares in the near term.

Should You Invest $1,000 in Allot Right Now?

Before you consider Allot, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allot wasn't on the list.

While Allot currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Nathan Reiff
About The Author

Nathan Reiff

Contributing Author

Fundamental Analysis, ETFs, Consumer Staples, Dividends

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Allot (ALLT)
1.4247 of 5 stars
$9.88-3.8%N/A-197.60Strong BuyN/A
Ardent Health (ARDT)
3.4387 of 5 stars
$13.441.7%N/A7.43Moderate Buy$19.33
Group 1 Automotive (GPI)
3.9043 of 5 stars
$448.16-1.3%0.45%12.36Hold$476.57
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

AI vs. Wall Street: 5 Names It Loves Right Now
3 Growth Stocks to Buy Now… and 3 to Dump Fast
These Sectors Are On Fire: Breaking Down the Market’s Biggest Gainers

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines